🇺🇸 FDA
Patent

US 9526747

Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure

granted A61KA61K2035/124A61K35/34

Quick answer

US patent 9526747 (Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure) held by Regents of the University of Minnesota expires Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Regents of the University of Minnesota
Grant date
Tue Dec 27 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 22 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2035/124, A61K35/34, A61P, A61P9/00